Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 8Breast 4Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 4Peripheral Nervous System Diseases 1Neuritis 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Diffusion Tensor Imaging × Breast × Clear all
NCT02812589 2021-04-13

Diffusion Tensor Breast MRI (DTI)

University Health Network, Toronto

Phase NA Completed
267 enrolled
Breast

Breast Neoplasms

NCT03365895 2020-11-19

CIPN

University of Arizona

Phase NA Completed
17 enrolled
Breast

Breast Neoplasms, Neuritis, Peripheral Nervous System Diseases

NCT01910298 2019-12-04

ESSBR

LifeCell

Phase NA Terminated
131 enrolled 14 charts
Breast

Breast Neoplasms

NCT02830685 2016-10-03

PreBRec

Guy's and St Thomas' NHS Foundation Trust

Phase 3 Unknown
131 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡